Media

Are You Doing Your Due Diligence? – Brought to you by MEMOTEXT‏

16 Steps to m/Digital Health Success

Posted on April 2, 2015 by Amos Adler

As mobile and digital health get more and more traction, you might be evaluating various m/digital health technologies and solutions. From new-starts to established legacy service providers there are a lot of options to choose from. It pays to have some digital health due-diligence planning in place. Fortunately, we at MEMOTEXT have learned some digital health lessons in due-diligence and hope to speed up the process for you. Don’t worry, we validated this methodology ourselves the hard way!

1 April 2015

Vote MEMOTEXT for the 3rd Annual Scattergood Foundation Innovation Award!

Updated on April 6, 2015 by Noah Nemoy

Dear friends,

MEMOTEXT is honored that our patient adherence solutions have been selected as a finalist for the 3rd Annual Scattergood Foundation Innovation Award! This prestigious award recognizes innovation breakthroughs in the field of behavioral health-care.

31 March 2015

MEMOTEXT Goes to Boston for Unpack! 2015

Posted on March 30, 2015 by Amos Adler

On March. 17 – 18 2015, MEMOTEXT had the honor to attend the Unpack! 2015. Represented by our Founder and President Amos Adler, MEMOTEXT was one of 15 Canadian digital/mobile health companies invited to attend. Unpack! 2015 was organized by the Canadian Entrepreneurs in New England (CENE), and facilitated by the Consulate General of Canada in Boston. The goal of the two day event was to connect Canadian Telehealth & Healthcare Robotics Companies with their Boston based American counterparts.

30 March 2015

MEMOTEXT Does it’s Part to Help Fight Glaucoma

Posted on March 11, 2015 by Noah Nemoy

This March 8-15, is World Glaucoma Week. Launched 6 years ago by the World Glaucoma Association and The World Glaucoma Patient Association, events are being held across the world to raise awareness about Glaucoma. Afflicting 9 million people, Glaucoma is the world’s leading cause of irreversible blindness. Due to its slow progression, 50% of patients in the developed world and 90% in the developing world are untreated. While Glaucoma is currently incurable, with early detection and treatment, its progression can be halted.

13 March 2015

You can change the system: How Estonia has built the most advanced eHealth system in the world

Posted on March 09, 2015 by Noah Nemoy

Perhaps the best thing about being a MaRS based start-up is attending the guest lectures. MaRS regularly hosts global experts in science and technology, and their discussions are extremely enlightening. Last month’s lecture, given by the former CEO of the Estonia eHealth Foundation Dr. Madis Tiik, was no exception. A common frustration with mHealth start-ups is that the healthcare systems they operate under are rigid, monolithic, and resistant to change. However, Dr. Tiik’s inspiring presentation showed that a nationwide eHealth system is indeed possible.

9 March 2015

Are you ready for this?… Behavior change…For your organization.

Posted on March 05, 2015 by Amos Adler

Some of our MEMOTEXT programs personalize interventions based on what’s known as stages of change. Stage of change, or the transtheoretical model, is used to asses and prescribe appropriate information, motivation and guidance to move people towards behavior change. In plain English, are people ready to adopt healthier behaviors?

4 March 2015

Innovation Resiliency: An Innovative Framework to Evaluate Innovation

Posted on March 02, 2015 by Amos Adler

WARNING: This blog post may offend some innovation seekers while inspiring others

I recently had an interaction with an organization supports innovation in knowledge-based industries. Several discussions with a representative of the organization revealed to me something that was a bit more common than I wanted to acknowledge: There are a lot of organizations that support the idea of innovation but have no real framework for it.

2 March 2015

MEMOTEXT’s Amos Adler Guest Lectures at U of T

Posted on February 26, 2015 by Noah Nemoy

On February 25, 2014, MEMOTEXT Founder and President Amos Adler was invited to give a guest lecture at the University of Toronto. This honor was fresh off the heels of MEMOTEXT’s participation at the University of Toronto’s Rotman School of Management’s IT in Healthcare Speaker Series earlier this month. The lecture was presented to Prof. Joseph Cafazzo’s Health Informatics class.

26 February 2015

MEMOTEXT’s Amos Adler Presents at the Rotman School of Management

Posted on February 12, 2015

On February 11, 2014, MEMOTEXT was one of the 5 MaRS based mHealth/digital health start-ups, invited to speak at the University of Toronto’s Rotman School of Management’s IT in Healthcare Speaker Series: Start-Ups. MEMOTEXT Founder and President Amos Adler spoke about how MEMOTEXT’s mhealth/digital health communication platform cuts costs for all stakeholders in the healthcare system and delivers clinically proven increases to adherence.

12 February 2015

mHealth: You’re doing it wrong.

Posted on February 9, 2015 by Noah Nemoy

The mHealth market is experiencing explosive growth and countless healthcare related apps are being developed. But simply developing an app does not make it an instant success. As the ARC 360 “2015 State Of The U.S. Health & Fitness Apps Economy” report shows, it is utility and taking user concerns into account, that makes an mHealth app successful.

9 February 2015

MEMOTEXT in 2014 part of the growth of mHealth Companies

Posted on February 6, 2015 by Noah Nemoy

The past year has been one of tremendous growth and new opportunities for both MEMOTEXT – one of the pioneering mHealth companies – and mHealth as a whole. The two trends that power the mHealth revolution; increased usage of mobile technology and the move towards decentralized and personalized health care, have continued unabated. While mHealth is an industry still largely in its infancy, the use of this technology will only increase as the gap between the 10% of smartphone owners using health apps and 72% of patients using mobile apps, continues to close.

6 February 2015

They’re Not Just “Feelings”: Why We Should Pay Attention to the Way People Feel About Their Medications

Posted on February 2, 2015 by Bill Simpson

I am not a medical historian, but I would bet that if you asked one, they would identify the synthesis of Aspirin in 1897 as one of most significant moments in modern medicine. With its pain-relieving, anti-inflammatory and anti-platelet (blood thinning) properties packaged within a single tablet, Aspirin provided a safe, effective and easy treatment for a wide range of illnesses. Even today, it is listed on the World Health Organization’s List of Essential Medicines and is taken daily by millions of people for the prevention of heart attacks and strokes. Its synthesis (and the pharmaceutical revolution it helped to user in) has no doubt helped to increase our lifespan and bring about a higher quality of life.

2 February 2015